4//SEC Filing
Mayersohn Joel David 4
Accession 0001213900-25-073136
CIK 0001851484other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:02 PM ET
Size
6.5 KB
Accession
0001213900-25-073136
Insider Transaction Report
Form 4
Mayersohn Joel David
Director
Transactions
- Other
Common Stock
2025-07-28+21,228→ 21,228 total
Holdings
- 250,000
Stock Option (Right to Buy)
Exercise: $1.07Exp: 2034-12-12→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]The shares were acquired through a distribution in kind to limited partners of 10XYZ Holdings, which was the Sponsor of TenX Keane Acquisition ("TenX"), the legacy entity of Citius Oncology, Inc.
- [F2]The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001588395
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:02 PM ET
- Size
- 6.5 KB